Zhang, D., Li, Y., Liu, Y., Xiang, X., & Dong, Z. (2013). Paclitaxel Ameliorates Lipopolysaccharide-Induced Kidney Injury by Binding Myeloid Differentiation Protein-2 to Block Toll-Like Receptor 4–Mediated Nuclear Factor-κB Activation and Cytokine Production. The American Society for Pharmacology and Experimental Therapeutics.
Citação norma ChicagoZhang, Dongshan, Yijian Li, Yu Liu, Xudong Xiang, and Zheng Dong. Paclitaxel Ameliorates Lipopolysaccharide-Induced Kidney Injury By Binding Myeloid Differentiation Protein-2 to Block Toll-Like Receptor 4–Mediated Nuclear Factor-κB Activation and Cytokine Production. The American Society for Pharmacology and Experimental Therapeutics, 2013.
Citação norma MLAZhang, Dongshan, et al. Paclitaxel Ameliorates Lipopolysaccharide-Induced Kidney Injury By Binding Myeloid Differentiation Protein-2 to Block Toll-Like Receptor 4–Mediated Nuclear Factor-κB Activation and Cytokine Production. The American Society for Pharmacology and Experimental Therapeutics, 2013.